ZIM
ABMD

Zacks Investment Management’s Abiomed Inc ABMD Stock Holding History

Zacks Investment Management’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-637
Closed -$229K – 686
2021
Q4 		$229K Sell
637
-7
-1% -$2.37K ﹤0.01% 574
2021
Q3 		$210K Buy
+644
New +$218K ﹤0.01% 573
2019
Q2 		– Sell
-2,900
Closed -$828K – 633
2019
Q1 		$828K Buy
2,900
+94
+3% +$31.2K 0.02% 417
2018
Q4 		$912K Buy
2,806
+83
+3% +$28.8K 0.02% 362
2018
Q3 		$1.23M Sell
2,723
-76
-3% -$30K 0.03% 365
2018
Q2 		$1.15M Buy
+2,799
New +$1.01M 0.02% 392
2018
Q1 		– Sell
-5,042
Closed -$945K – 644
2017
Q4 		$945K Sell
5,042
-4,569
-48% -$853K 0.02% 414
2017
Q3 		$1.62M Sell
9,611
-6,093
-39% -$921K 0.04% 283
2017
Q2 		$2.25M Buy
+15,704
New +$2.11M 0.06% 219
2016
Q4 		– Sell
-3,271
Closed -$421K – 766
2016
Q3 		$421K Sell
3,271
-8,342
-72% -$999K 0.01% 463
2016
Q2 		$1.27M Sell
11,613
-3,732
-24% -$371K 0.04% 283
2016
Q1 		$1.46M Buy
+15,345
New +$1.3M 0.05% 256

Other funds holding ABMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $11.2B AUM 0.58% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Zacks Investment Management's ABMD Position: Q1 2022 in Review

Zacks Investment Management sold out of Abiomed Inc (ABMD) in Q1 2022, closing a stake of 637 shares — an estimated $229K sold.

Zacks Investment Management first reported a position in ABMD in Q1 2016 and held it in 12 quarters. The position peaked at $2.25M in Q2 2017. 500 funds tracked by Wall St. Rank hold ABMD as of Q1 2022.

  • Zacks Investment Management reported no remaining Abiomed Inc position as of Q1 2022 after selling out during the quarter.
  • Zacks Investment Management sold 637 Abiomed Inc shares in Q1 2022, an estimated $229K.
  • Zacks Investment Management first reported a position in Abiomed Inc in Q1 2016 and held it in 12 quarters.
  • Zacks Investment Management's Abiomed Inc position peaked at $2.25M in Q2 2017.
  • 500 funds tracked by Wall St. Rank held Abiomed Inc as of Q1 2022.

Based on Zacks Investment Management's 13F filing for Q1 2022, filed 13 May 2022.